We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Congoleum Corp | AMEX:CGM | AMEX | Ordinary Share |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From Mar 2020 to Mar 2025
Third quarter financial report
IFRS – Regulated Information – Not audited
Regulatory News:
Cegedim, an innovative technology and services company, generated consolidated third quarter 2015 revenues from continuing activities of €120.4 million, up 0.9% like for like and 3.5% on a reported basis compared with the same period in 2014.
The decline in like-for-like revenues at the Healthcare Professionals division was more than offset by relative stability at the Cegelease division and growth at the Health Insurance, HR and e-services division. The Health Insurance, HR and e-services division made a noteworthy return to strong growth despite the migration of clients towards SaaS and cloud offerings.
The Group is laying the groundwork for its future by migrating its software offerings from a perpetual license model to an SaaS / cloud model, but the effort has a short-term cost in terms of revenues and profitability. In the long term, the move will enhance Cegedim’s customer loyalty, bring it closer to its customers, and simplify its operating processes. As a result, the share of recurring revenues will increase, making growth stronger and more predictable.
At the same time, the Group continues to strengthen its businesses through targeted acquisitions. In late July, the Group bought Activus in the UK in order to bolster its presence in software for the health insurance and personal insurance fields in English-speaking countries. In early October, Cegedim bought the US assets of Nightingale to enhance its offerings of EHR products in cloud / SaaS format in the US.
Lastly, the Group is actively working to improve its debt profile.
In light of the rapid development of its BPO (Business Process Outsourcing) and SaaS / cloud business, which requires personnel investments to get clients up and running, and given the investments necessary for migrating all of its software products from perpetual license models to cloud / SaaS format, Cegedim is having to revise downward its expectations for 2015 revenue and EBIT before special items. Cegedim now expects like-for-like revenue growth of 1% and a 5% increase in EBITDA.
In the third quarter of 2015, Cegedim generated consolidated revenues from continuing activities of €120.4 million, up 3.5% on a reported basis and 0.9% like for like compared with the same period in 2014. Acquisitions and currencies have a positive impact of respectively 1.0% and 1.5%.
Over the first nine months of 2015, continuing activities had revenues of €366.6 million, up 3.3% on a reported basis and 1.0% like-for-like compared with the same period in 2014. Acquisitions and currencies have a positive impact of respectively 0.3% and 1.9%. Group revenues, including the Q1 revenues of the activities sold on April 1, 2015, came to €468.2 million, down 27.1% on a reported basis and up 1.6% like for like compared with the year-earlier period.
Analysis of business trends by division
Over the first nine months of 2015, division revenues came to €167.5 million, up 6.0% on a reported basis. The acquisition of Activus, in July 2015 in the UK, made positive contributions of 0.7%. Currencies had virtually no impact. Like-for-like revenues grew 5.2% over the period.
The Health Insurance, HR and e-services division represented 45.7% of consolidated revenues from continuing activities, compared with 44.5% during the same period a year earlier.
In the third quarter of 2015, division revenues came to €55.9 million, up 8.7% on a reported basis. The acquisition of Activus, in July 2015 in the UK, made positive contributions of 2.2%. Currencies had virtually no impact. Like-for-like revenues grew 6.4% over the period.
Robust Q3 revenue growth was chiefly the result of:
Over the first nine months of 2015, division revenues came to €113.0 million, up 1.4% on a reported basis. Currency effects made positive contributions of 6.0 %. Acquisitions had virtually no impact. Like-for-like revenues fell 4.7% over the period.
The Healthcare Professionals division represented 30.8% of consolidated revenues from continuing activities, compared with 31.4% during the same period a year earlier.
In the third quarter of 2015, division revenues amounted to €36.5 million, a 1.3% decrease on a reported basis. There were no acquisitions or divestments, and currencies made a positive contribution of 4.8%. Like-for-like revenues fell 6.1% over the period.
This performance was chiefly the result of:
Over the first nine months of 2015, division revenues came to €83.3 million, up 0.3% on a reported basis and like for like. There were no acquisitions or divestments, and currencies had no impact.
The Cegelease division represented 22.7% of consolidated revenues from continuing activities, compared with 23.4% during the same period a year earlier.
In the third quarter of 2015, division revenues came to €27.2 million, down 0.3% on a reported basis and like for like. There were no acquisitions or divestments, and currencies had no impact.
Sales were virtually unchanged in the third quarter, mainly because of a different mix of self-financed and resold contracts in 2015 than in 2014. The favorable trend in financing conditions led the Group to reduce the proportion of self-financed contracts.
Over the first nine months of 2015, division revenues came to €2.8 million, up 18.5% on a reported basis and like for like. There were no acquisitions or divestments, and currencies had no impact.
The Activities not allocated division represented 0.8% of consolidated revenues from continuing activities, compared with 0.7% during the same period a year earlier.
In the third quarter of 2015, division revenues came to €0.8 million, up 17.5% on a reported basis and like for like. There were no acquisitions or divestments, and currencies had no impact.
The third-quarter increase was chiefly attributable to services, including IT services, invoiced to IMS Health.
3rd quarter highlights
Cegedim redeemed the full amount of the €62.6 million remaining in circulation of the 7.0% 2015 bond upon maturity on July 27, 2015 (ISIN : FR0010925172).
Between July 1, 2015, and the release date of this document, Cegedim redeemed on the market its 6.75% bond, maturing April 1, 2020, ISIN code XS0906984272, for a total principal amount of €19,470,000. The company then cancelled these bonds. As a result, a total principal amount of €343,346,000 remains in circulation.
On July 20th 2015, Cegedim announces the acquisition of 100% of Activus, one of the UK’s leading suppliers of health and protection insurance software. This deal gives Cegedim Health Insurance access to new markets (UK, US, Middle East, APAC, Africa,…) and strengthens its software offering for international clients. Activus generated revenue of around €7 million in 2014.
This move is part of the Group’s strategy of making bolt-on acquisitions to expand its international positions. The deal was financed with internal financing. It will contribute to Cegedim consolidated results starting from the acquisition date.
At end-September, movements in exchange rates were positive, contributing €1.8 million to consolidated third quarter revenues from continuing activities.
On September 24, 2015, the Paris Court of Appeal rejected Cegedim’s request and upheld the Competition Authority decision of July 8, 2014. Because the fine was paid in full in September 2014, this decision has no impact on Cegedim’s accounts.
Cegedim had appeal of this decision to the Court of Cassation.
Apart from the items cited above, to the best of the company’s knowledge, there were no events or changes during the period that would materially alter the Group’s financial situation.
Significant post-closing transactions and events
In early October 2015, Cegedim announced that its US subsidiary, Pulse Systems, Inc., acquired the US healthcare management activities of Nightingale Informatix Corporation, including Medrium, Ridgemark, Secure Connect and Northern Health Products. Pulse will now be able to offer its clients healthcare and EHR management products in client-server and cloud format.
Apart from the items cited above, to the best of the company’s knowledge, there were no post-closing events or changes that would materially alter the Group’s financial situation.
Outlook
In light of the rapid development of its BPO and SaaS / cloud business, which requires personnel investments to get clients up and running, and given the investments necessary for migrating all of its software products from perpetual license models to cloud / SaaS format, Cegedim is having to revise downward its expectations for 2015 revenue and EBIT before special items. Cegedim now expects like-for-like revenue growth of 1% and a 5% increase in EBITDA.
The Group does not anticipate any significant acquisitions for 2015 and does not disclose profit projections or estimates.
Financial calendar
The Group will hold a conference call today on October 27, 2015, at 6:15 pm in English (Paris time). The call will be hosted by Jan Eryk Umiastowski, Cegedim Chief Investment Officer and Head of Investor Relations.
A presentation of Cegedim Q3 2015 Revenue will also be available on the website: http://www.cegedim.com/finance/documentation/Pages/presentations.aspx
Contact numbers:
France: +33 1 70 77 09 44US : +1 866 907 5928
UK and others: +44 (0)20 3367 9453
No Access code required
November 26, 2015 (after the stock market closes)
December 17, 2015 at 2pm CET
Additional information
Complete financial information and a presentation on Cegedim’s third quarter revenue are available on our website: www.cegedim.com/finance.
This information is also available on Cegedim IR, the Group’s financial communications app for smartphones and iOS and Android tablets. To download the app, visit: http://www.cegedim.fr/finance/profil/Pages/CegedimIR.aspx.
Appendices
# Figures rounded to the nearest unit
Year 2015
€ thousands Q1 Q2 Q3 Q4 Total Health Insurance, HR and e-services 54,004 57,546 55,912 167,462 Healthcare professionals 37,187 39,352 36,456 112,995 Cegelease 29,293 26,842 27, 208 83,342 Activities not allocated 825 1,100 843 2,768 Group 121,309 124,839 120,419 366,567Year 2014
€ thousands Q1 Q2 Q3 Q4 Total Health Insurance, HR and e-services 49,801 56,801 51,445 158,047 Healthcare professionals 36,906 37,617 36,931 111,453 Cegelease 25,867 29,971 27,295 83,133 Activities not allocated 796 823 717 2,336 Group 113,370 125,211 116,388 354,969Activities not allocated: this division encompasses the activities the Group performs as the parent company of a listed entity, as well as the support it provides to the three operating divisions.
EPS: Earnings Per Share is a specific financial indicator defined by the Group as the net profit (loss) for the period divided by the weighted average of the number of shares in circulation.
Operating expenses: defined as purchases used, external expenses and payroll costs.
Revenue at constant exchange rate: when changes in revenue at constant exchange rate are referred to, it means that the impact of exchange rate fluctuations has been excluded. The term “at constant exchange rate” covers the fluctuation resulting from applying the exchange rates for the preceding period to the current fiscal year, all other factors remaining equal.
Revenue on a like-for-like basis: the effect of changes in scope is corrected by restating the sales for the previous period as follows:
• by removing the portion of sales originating in the entity or the rights acquired for a period identical to the period during which they were held to the current period;
• similarly, when an entity is transferred, the sales for the portion in question in the previous period are eliminated.
Life-for-like data: at constant scope and exchange rates.
Internal growth: internal growth covers growth resulting from the development of an existing contract, particularly due to an increase in rates and/or the volumes distributed or processed, new contracts, acquisitions of assets allocated to a contract or a specific project.
External growth: external growth covers acquisitions during the current fiscal year, as well as those which have had a partial impact on the previous fiscal year, net of sales of entities and/or assets.
EBIT: Earnings Before Interest and Taxes. EBIT corresponds to net revenue minus operating expenses (such as salaries, social charges, materials, energy, research, services, external services, advertising, etc.). It is the operating income for the Cegedim Group.
EBIT from recurring operations: this is EBIT restated to take account of non-current items, such as losses on tangible and intangible assets, restructuring, etc. It corresponds to the operating income from recurring operations for the Cegedim Group.
EBITDA: Earnings before interest, taxes, depreciation and amortization. EBITDA is the term used when amortization or depreciation and revaluations are not taken into account. “D” stands for depreciation of tangible assets (such as buildings, machines or vehicles), while “A” stands for amortization of intangible assets (such as patents, licenses and goodwill). EBITDA is restated to take account of non-current items, such as losses on tangible and intangible assets, restructuring, etc. It corresponds to the gross operating earnings from recurring operations for the Cegedim Group.
Net Financial Debt: this represents the Company’s net debt (non-current and current financial debt, bank loans, debt restated at amortized cost and interest on loans) net of cash and cash equivalents and excluding revaluation of debt derivatives.
Free cash flow: free cash flow is cash generated, net of the cash part of the following items: (i) changes in working capital requirements, (ii) transactions on equity (changes in capital, dividends paid and received), (iii) capital expenditure net of transfers, (iv) net financial interest paid and (v) taxes paid.
Operating margin: defined as the ratio of EBIT/revenue.
Operating margin from recurring operations: defined as the ratio of EBIT from recurring operations/revenue.
Net cash: defined as cash and cash equivalent minus overdraft.
About Cegedim:Founded in 1969, Cegedim is an innovative technology and services company in the field of digital data flow management for healthcare ecosystems and B2B, and a business software publisher for healthcare and insurance professionals. Cegedim employs almost 3,500 people in 11 countries and generated revenue of €494 million in 2014. Cegedim SA is listed in Paris (EURONEXT: CGM).
To learn more, please visit: www.cegedim.com
And follow Cegedim on Twitter: @CegedimGroup
Public company with share capital of 13,336,506.43 eurosTrade and Commercial Register: Nanterre B 350 422 622www.cegedim.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20151027006689/en/
CegedimMedia RelationsAude BALLEYDIER, +33 (0)1 49 09 68 81aude.balleydier@cegedim.frorInvestor RelationsJan Eryk UMIASTOWSKI, +33 (0)1 49 09 33 36Chief investment Officerinvestor.relations@cegedim.frorPRPA AgencyMedia RelationsGuillaume DE CHAMISSO, +33 (0)1 46 99 69 69guillaume.dechamisso@prpa.fr
1 Year Congoleum Chart |
1 Month Congoleum Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
